Skip to main content

MoneyWorks4Me

Zydus Lifesciences informs about press release

21 Oct 2026 Evaluate
Zydus Lifesciences has informed that it enclosed a copy of press release dated October 21, 2026, titled ‘Zydus receives USFDA approval for Estradiol and Levonorgestrel Transdermal System, eligible for 180-day CGT exclusivity’. The contents of the press release give full details.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1893.75
Dr. Reddys Labs. 1377.50
Cipla 1414.25
Lupin 2008.00
Zydus Lifesciences 1200.90
View more..